P and T data 2.pdf

This document appears to be a compilation of medical and pharmaceutical data reports from Centurion, focusing on various healthcare metrics for Q4 2024. The materials include detailed analytics on medication spending, medication categories, generic drug reviews, medication shortages, and backordered medication lists. Key sections cover topics such as Top 50 Medications by Spend, Medication Category Spending, Primary and Secondary Medication Category Breakouts, Credits, Cost Trends, and Medication Shortages and Backordered Lists.

The financial data indicates significant healthcare spending across multiple medication categories, with varied spending levels ranging from tens of thousands to hundreds of thousands of dollars. The reports provide granular insights into medication utilization, spending patterns, and potential supply chain challenges. Notably, the data is segmented by different time periods (monthly and quarterly), offering a comprehensive view of medication trends, costs, and potential strategic procurement considerations for healthcare organizations. The reports seem designed to support strategic decision-making in pharmaceutical procurement, inventory management, and budgeting.